期刊文献+

原核表达重组质粒pUC57-CTP-PTEN的构建及鉴定

Construction and identification of the prokaryotic expression recombinant plasmid pUC57-CTP-PTEN
下载PDF
导出
摘要 目的:合成基因CTP及PTEN基因,构建其原核表达重组质粒pUC57-CTP-PTEN,为后续研究其功能做准备。方法:合成基因CTP-PTEN,将该基因定向克隆到原核表达载体pUC57中,构建pUC57-CTP-PTEN重组质粒,转化大肠杆菌DH5α菌株,抽提质粒进行双酶切、测序鉴定后,用Western blotting检验表达。结果:测序鉴定CTP-PTEN基因合成成功。经双酶切、测序鉴定证实重组质粒pUC57-CTP-PTEN成功转入DH5α,Western blotting检验pUC57-CTP-PTEN成功表达。结论:成功构建了重组质粒pUC57-CTP-PTEN,并在大肠杆菌DH5α中成功表达。 Objective: To construct prokaryotic expression recombinant plasmid p UC57- CTP- PTEN of CTP gene and PTEN gene,and prepare for the follow- up study of its function. Methods: Gene CTP- PTEN was synthesized and cloned into the prokaryotic expression vector p UC57 to construct the recombinant plasmid p UC57- CTP-PTEN. Then it was transformed into E. coli DH5 α. The recombinant plasmid was identified by restriction enzyme digestion and DNA sequencing. The expression product was identified by Western blotting assay. Results: Gene CTP-PTEN was successfully synthesized. The recombinant plasmid p UC57- CTP- PTEN was identified that it was successfully transformed into E. coli DH5 α and expressed by restriction enzyme digestion,DNA sequencing and Western blotting. Conclusion: The recombinant plasmid p UC57- CTP- PTEN was successfully constructed and expressed in E. coli DH5 α.
出处 《现代肿瘤医学》 CAS 2017年第4期528-530,共3页 Journal of Modern Oncology
基金 成都市医学科研课题(编号:2014001) 成都学院校青年基金项目(编号:2014XJZ08) 成都大学附属医院院内课题(编号:2014016)
关键词 质粒pUC57 CTP PTEN 构建 鉴定 plasmid pUC57 CTP PTEN construction identification
  • 相关文献

参考文献1

二级参考文献31

  • 1Te HS and Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010, 14:1-21.
  • 2Raney AK, Hamatake RK and Hong Z. Agents in clinical development for the treatment of chronic hepatitis B. Expert Opin Investig Drugs 2003, 12: 1281-1295.
  • 3Lohr HF, Krug S, Herr W, Weyer S, Schlaak J, W61fel T and Gerken G, et al. Quantitative and ftmctional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B. Liver 1998, 18: 405-413.
  • 4Webster G J, Reignat S, Maini MK, Whalley SA, Ogg GS, King A and Brown D, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000, 32:1117-1124.
  • 5Yang SH, Lee CG and Park SH. Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study. Gene Ther 2006, 13:1110-1117.
  • 6Bertoletti A, Maini M and Williams R. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res 2003, 60: 61-66.
  • 7Momburg F and Tan P. Tapasin--the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum. Mol Immunol 2002, 39: 217-233.
  • 8Grandea AG, III and Van Kaer L. Tapasin: an ER chaperone that controls MHC class I assembly with peptide. Trends Immuno12001, 22: 194-199.
  • 9Brooke P, Garbi N, Momburg F and Himmerling GJ. HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr Opin Immunol 2002, 14: 22-29.
  • 10Lehner P J, Surman MJ and Cresswell P. Soluble tapasin restores MHC class I expression and fimction in the tapasin-negative cell line .220. Immunity 1998, 8: 221-231.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部